Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2004C023 Product name: EFALIZUMAB.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
2004C/023
Type:
Certificate
SPC type:
Medical
Basic patent number:
979128410
Status:
SPC Expired
Publication number:
2004C023
1rst applicant's nationality:
Procedural language:
French

Marketing authorization

1

Marketing authorization number:
EU/1/04/291/001
Marketing authorization type:
National/EU
Designates country:
No
Marketing authorization date:
21/09/2004
Marketing authorization status:
Accepted
Marketing authorization country:
Belgium (BE)

2

Marketing authorization number:
56714
Marketing authorization type:
EEA
Designates country:
Yes
Marketing authorization date:
09/03/2004
Marketing authorization status:
Accepted
Marketing authorization country:
Switzerland (CH)

Dates

Filing date:
24/11/2004
First marketing authorization date:
09/03/2004
Grant date:
07/06/2005
Activation date:
20/10/2017
BE Publication date:
07/06/2005
Lapsed date:
Expiration date (if granted and all annual fees paid):
Basic SPC Expiration (if granted and all annual fees paid):
09/03/2019
SPC/SPC Extension Expiration (if granted and all annual fees paid):
09/03/2019
Rejection date:
Withdrawal date:

Applicant

Name:
GENENTECH, INC.
Legal Form:
From:
24/11/2004
Address:
1 DNA Way, South San Francisco CA 94080-4990, United States (US)
To:

Agent

Name:
de KEMMETER François
Legal Form:
From:
24/11/2004
Address:
Boulevard Général Wahis 15, 1030, BRUXELLES, Belgium (BE)
To:

Publication

Bulletin

1

Bulletin heading:
SPC
Journal edition number:
2005/06
Publication date:
30/06/2005
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

2

Bulletin heading:
SPC
Journal edition number:
2017/20
Publication date:
05/02/2018
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

3

Bulletin heading:
VRV
Journal edition number:
2019/08
Publication date:
02/05/2019
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
16/10/2018
Last annual fee paid number:
22
Last annual fee paid amount:
700 Euro
Payer:
NOVAGRAAF INTERNATIONAL SA
Filing date Document type Publication Type Document Description Number of pages File Type
Certificate PDF /3/2/0/4/0/0300004023/migrated-docs/2004CSLASH023_0_2004C023.pdf